Top Markets
Coin of the day
Prince Pharmaceutical Co., Ltd. Prince Pharmaceutical Co., Ltd.

Prince Pharmaceutical Co., Ltd.

6935
Rangering i aksjer #27310
Prince Pharmaceutical Co., Ltd. operates in the production and global sale of... Prince Pharmaceutical Co., Ltd. operates in the production and global sale of active pharmaceutical ingredients (APIs), primarily focusing on vitamin B1. Its market presence extends across Taiwan, Japan, Korea, and other international territories. The company's product portfolio also encompasses a variety of consumer health items and general medicines. These offerings include popular formulations such as vitamin C tablets and vitamin B complex tablets, alongside specialized supplements like natto and rhodiola extract capsules, probiotic sachets, and various plant extract capsules. In addition to vitamin B1, Prince Pharmaceutical supplies a comprehensive array of other APIs, notably felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. The company's distribution network specifically includes countries within Spain and the wider European continent. Established in 1962, Prince Pharmaceutical Co., Ltd. is based in Yunlin County, Taiwan.
Aksjekurs
$0.89991249
Markedsverdi
$33.67M
Endring (1 dag)
-0.35%
Endring (1 år)
7.33%
Land
TW
Handel Prince Pharmaceutical Co., Ltd. (6935)

Kategori

P/B-forhold for Prince Pharmaceutical Co., Ltd. (6935)
P/B-forhold per 2026 TTM: 0
Ifølge Prince Pharmaceutical Co., Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for Prince Pharmaceutical Co., Ltd. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter